ORCL
49
3
A
54
8
CCI
62
10
FLS
30
-2
PH
50
-2
SRE
42
4
PBI
35
2
ITW
50
10
KO
92
24
WDC
55
2
BBBY
24
4
LYB
6
4
LNC
85
35
FAST
52
6
SO
100
25
HCA
35
2
XEL
85
32
ESS
45
3
D
61
16
IBM
65
2
ORCL
49
3
A
54
8
CCI
62
10
FLS
30
-2
PH
50
-2
SRE
42
4
PBI
35
2
ITW
50
10
KO
92
24
WDC
55
2
BBBY
24
4
LYB
6
4
LNC
85
35
FAST
52
6
SO
100
25
HCA
35
2
XEL
85
32
ESS
45
3
D
61
16
IBM
65
2
*Stock Score changes are based on previous closing prices
Financhill
Back

Amgen 10K Form

Sell
50

AMGN
Amgen

Last Price:
245.38
Seasonality Move:
9.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-04-28 10Q AMGN/Amgen Quarterly
2021-02-09 10K AMGN/Amgen Annual
2020-10-29 10Q AMGN/Amgen Quarterly
2020-07-29 10Q AMGN/Amgen Quarterly
2020-05-01 10Q AMGN/Amgen Quarterly
2020-02-13 10K AMGN/Amgen Annual

Receive AMGN News And Ratings

See the #1 stock for the next 7 days that we like better than AMGN

AMGN Financial Statistics

Sales & Book Value

Annual Sales: $25.98B
Cash Flow: $1.97B
Price / Cash Flow: 16.48
Annual Sales: $1.71
Price / Book: 143.1

Profitability

EPS (TTM): 10.16000
Net Income (TTM): $5.72B
Gross Margin: $19.53B
Return on Equity: 85.64%
Return on Assets: 9.3%

Amgen Earnings Forecast

Key Amgen Financial Ratios

  • The Gross Profit Margin over the past 38 years for AMGN is 75.16%.
  • The Selling, General & Administrative Expenses for AMGN have been equal to 20.66% of Gross Profit Margin.
  • The Research & Development expenses have been 18.55% of Revenue.
  • The Interest Expense is 20.31% of Operating Income.
  • The Net Earning history of AMGN is 22.68% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 24 years.

Amgen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: AMGN
CUSIP: 031162
Website: amgen.com

Debt

Debt-to-Equity Ratio: 40.23
Current Ratio: 1.44
Quick Ratio: 0.9

Price-to-Earnings

Trailing P/E Ratio: 23.87
Forward P/E Ratio: 12.87

AMGN Technical Analysis vs Fundamental Analysis

Sell
50
Amgen (AMGN) is a Sell

Is Amgen a Buy or a Sell?

  • Amgen stock is rated a Sell
    The current Amgen [AMGN] share price is $245.37. The Score for AMGN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.